USPTO 2015–2025 USPTO PatentsView US Corporation

Otto Bock Healthcare LP

USPTO PatentsView assignee record - 85 granted patents across 34 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Otto ranks #4,215 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 34 technology areas.

#4,215
of 49,997 US assignees by volume
Top 11%
by Innovation Score (52.0/100)
16.4
avg claims per patent
-76%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4215 · US Corporation #4,215 · 85 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 85 grants
  • TOP-DECILE #4,215/49,997
  • PHOTO-FINISH Nobel Biocare Services
  • CPC-FOCUS A61F · 34 areas
  • INNOV-PAR 52.0/100
  • CLAIMS-RICH 16.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -76% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nobel Biocare Services AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Otto’s 52.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Otto

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Otto's Innovation Score is 52.0/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Otto?

Each dot is one of Otto’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Otto’s own 16.4 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Otto vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 84.985.085.08585.085.085.1 510152025 Granted patents (volume) Avg claims / patent Nobel Biocare Services AG - 85, 14.91Nobel Biocare Ser…O&M Halyard, Inc. - 85, 15.99O&M HalyardOcé Holding B.V. - 85, 13.32Océ Holding B VOmrix Biopharmaceuticals Ltd. - 85, 10.11Omrix Biopharmace…Pindrop Security, Inc. - 85, 19.98Pindrop SecurityPolygroup Macau Limited (BVI) - 85, 17.6Polygroup Macau (…Rotation Medical, Inc. - 85, 17.76Rotation MedicalSage Electrochromics, Inc. - 85, 19.31Sage Electrochrom…Otto Bock Healthcare LP - 85, 16.39Otto Bock Healthc…
Otto vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Otto's grants concentrate

Otto Bock Healthcare LP is a focused PatentsView assignee: 34 CPC subclasses with 78.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (19 grants) versus a trough of 2 in 2020. By volume, Otto sits between Nobel Biocare Services AG and Sage Electrochromics, Inc..

Otto's three-year grant acceleration

Otto Bock Healthcare LP shows 11 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Otto's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Otto holds 85 patents at rank #4,215, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Otto

By rank, the assignees closest to #4,215 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Otto's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Otto, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Otto ranks #88 of 3,082 assignees by patent count in that subclass.

Otto's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Otto Bock Healthcare LP patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 19 22.4%
2016 6 7.1%
2017 19 22.4%
2018 17 20.0%
2019 7 8.2%
2020 2 2.4%
2021 3 3.5%
2022 4 4.7%
2023 5 5.9%
2024 2 2.4%
2025partial year 1 1.2%

Which technologies does Otto Bock Healthcare LP patent most?

Top 15 of 34 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Otto Bock Healthcare LP's patent record in context - here's where to go next.

  • Otto Bock Healthcare LP's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 78.8% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #4,215 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Otto Bock Healthcare LP against Nobel Biocare Services AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.